Non-invasive lung cancer diagnosis and prognosis based on multi-analyte liquid biopsy

Mol Cancer. 2021 Jan 29;20(1):23. doi: 10.1186/s12943-021-01323-9.
No abstract available

Keywords: DNA methylation; Diagnosis; Liquid biopsy; Lung cancer; Multi-analyte; Mutation; Prognosis; cfDNA.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biomarkers, Tumor*
  • Cell-Free Nucleic Acids
  • DNA Methylation
  • Disease Management
  • Disease Susceptibility
  • Epigenesis, Genetic
  • Gene Expression Profiling
  • Genomics / methods
  • High-Throughput Nucleotide Sequencing
  • Humans
  • Liquid Biopsy / methods*
  • Liquid Biopsy / standards
  • Lung Neoplasms / diagnosis*
  • Mutation
  • Prognosis

Substances

  • Biomarkers, Tumor
  • Cell-Free Nucleic Acids